Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 4
2005 8
2006 6
2007 4
2008 9
2009 13
2010 14
2011 10
2012 5
2013 2
2014 8
2015 9
2016 4
2017 10
2018 6
2019 10
2020 15
2021 14
2022 9
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Implications of the 5th Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia.
Lee C, Kim HN, Kwon JA, Yoon SY, Jeon MJ, Yu ES, Kim DS, Choi CW, Yoon J. Lee C, et al. Among authors: choi cw. Ann Lab Med. 2023 Sep 1;43(5):503-507. doi: 10.3343/alm.2023.43.5.503. Epub 2023 Apr 21. Ann Lab Med. 2023. PMID: 37080752 Free PMC article.
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.
Kulasekararaj AG, Griffin M, Langemeijer S, Usuki K, Kulagin A, Ogawa M, Yu J, Mujeebuddin A, Nishimura JI, Lee JW, Peffault de Latour R; 301/302 Study Group. Kulasekararaj AG, et al. Eur J Haematol. 2022 Sep;109(3):205-214. doi: 10.1111/ejh.13783. Epub 2022 Jun 16. Eur J Haematol. 2022. PMID: 35502600 Free PMC article. Clinical Trial.
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.
Gill H, Leung GMK, Ooi MGM, Teo WZY, Wong CL, Choi CW, Wong GC, Lao Z, Rojnuckarin P, Castillo MRID, Xiao Z, Hou HA, Kuo MC, Shih LY, Gan GG, Lin CC, Chng WJ, Kwong YL. Gill H, et al. Among authors: choi cw. Clin Exp Med. 2023 Dec;23(8):4199-4217. doi: 10.1007/s10238-023-01189-9. Epub 2023 Sep 25. Clin Exp Med. 2023. PMID: 37747591 Review.
The 2020 revision of the guidelines for the management of myeloproliferative neoplasms.
Kim SY, Bae SH, Bang SM, Eom KS, Hong J, Jang S, Jung CW, Kim HJ, Kim HY, Kim MK, Kim SJ, Mun YC, Nam SH, Park J, Won JH, Choi CW. Kim SY, et al. Among authors: choi cw. Korean J Intern Med. 2021 Jan;36(1):45-62. doi: 10.3904/kjim.2020.319. Epub 2020 Dec 4. Korean J Intern Med. 2021. PMID: 33147902 Free PMC article. Review.
Guidelines for the management of myeloproliferative neoplasms.
Choi CW, Bang SM, Jang S, Jung CW, Kim HJ, Kim HY, Kim SJ, Kim YK, Park J, Won JH. Choi CW, et al. Korean J Intern Med. 2015 Nov;30(6):771-88. doi: 10.3904/kjim.2015.30.6.771. Epub 2015 Oct 30. Korean J Intern Med. 2015. PMID: 26552452 Free PMC article. Review.
Composite follicular lymphoma and classic Hodgkin lymphoma.
Kim HN, Jeon MJ, Yu ES, Kim DS, Choi CW, Ko YH. Kim HN, et al. Among authors: choi cw. J Pathol Transl Med. 2022 Jan;56(1):57-60. doi: 10.4132/jptm.2021.10.09. Epub 2021 Nov 16. J Pathol Transl Med. 2022. PMID: 34775730 Free PMC article.
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.
Kim YR, Kim JS, Kim WS, Eom HS, Yang DH, Bae SH, Kim HJ, Lee JH, Oh SJ, Yoon SS, Kwak JY, Choi CW, Kim MK, Oh SY, Kang HJ, Nam SH, Shim H, Park JS, Mun YC, Suh C; Korean Society of Hematology Lymphoma Working Party. Kim YR, et al. Among authors: choi cw. Cancer Res Treat. 2023 Oct;55(4):1355-1362. doi: 10.4143/crt.2023.271. Epub 2023 Mar 30. Cancer Res Treat. 2023. PMID: 36996864 Free PMC article. Clinical Trial.
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.
Kim JS, Jang JH, Jo DY, Ahn SY, Yoon SS, Lee JH, Kim SH, Choi CW, Shin HJ, Kim MK, Lee JH, Mun YC, Kong JH, Hyun B, Nam H, Kim E, Kwak MJ, Won YK, Lee JW. Kim JS, et al. Among authors: choi cw. J Korean Med Sci. 2023 Oct 23;38(41):e328. doi: 10.3346/jkms.2023.38.e328. J Korean Med Sci. 2023. PMID: 37873628 Free PMC article.
156 results